- Home
- GNLX vs ASPS Comparison
GNLX vs ASPS Comparison
Compare GNLX & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- ASPS
- Stock Information
- Founded
- GNLX 2001
- ASPS 1999
- Country
- GNLX United States
- ASPS Luxembourg
- Employees
- GNLX N/A
- ASPS N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- ASPS Other Consumer Services
- Sector
- GNLX Health Care
- ASPS Consumer Discretionary
- Exchange
- GNLX Nasdaq
- ASPS Nasdaq
- Market Cap
- GNLX 128.0M
- ASPS 123.2M
- IPO Year
- GNLX 2023
- ASPS N/A
- Fundamental
- Price
- GNLX $5.33
- ASPS $12.91
- Analyst Decision
- GNLX Strong Buy
- ASPS
- Analyst Count
- GNLX 4
- ASPS 0
- Target Price
- GNLX $17.75
- ASPS N/A
- AVG Volume (30 Days)
- GNLX 134.5K
- ASPS 31.5K
- Earning Date
- GNLX 11-13-2025
- ASPS 10-23-2025
- Dividend Yield
- GNLX N/A
- ASPS N/A
- EPS Growth
- GNLX N/A
- ASPS N/A
- EPS
- GNLX N/A
- ASPS N/A
- Revenue
- GNLX N/A
- ASPS $168,271,000.00
- Revenue This Year
- GNLX N/A
- ASPS $38.29
- Revenue Next Year
- GNLX N/A
- ASPS N/A
- P/E Ratio
- GNLX N/A
- ASPS N/A
- Revenue Growth
- GNLX N/A
- ASPS 12.96
- 52 Week Low
- GNLX $1.99
- ASPS $3.46
- 52 Week High
- GNLX $5.89
- ASPS $15.96
- Technical
- Relative Strength Index (RSI)
- GNLX 79.51
- ASPS 60.84
- Support Level
- GNLX $4.17
- ASPS $12.42
- Resistance Level
- GNLX $4.83
- ASPS $14.36
- Average True Range (ATR)
- GNLX 0.29
- ASPS 0.91
- MACD
- GNLX 0.07
- ASPS 0.18
- Stochastic Oscillator
- GNLX 96.35
- ASPS 59.27
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.